I listened to their presentation . My take is that they are focused on launching this drug themselves as 1) most pediatric patients are treated at just a few major Children's hospital 2) most tumor patients are treated at just a few Academic hospitals
So they only need a small # of highly trained med people to interact with these roughly 20 hospitals in the US .
Part of the current PPS is a spec on this Co being bought out . That was my view . However they definitely conveyed going it alone today JMO Kiwi